A Study of MGCD516 in Patients with Advanced Solid Tumors (17038)

A Study of MGCD516 in Patients with Advanced Solid Tumors (17038)

Trial Category:
Other Solid Tumor
Phase
I
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Nebraska Cancer Specialists, Omaha, NE

This study is looking at a new drug to assess its anti-tumor activity in multiple different solid tumors.  Please contact us for more information. 

 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members